60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.600
-0.020 (-1.23%)
At close: Apr 28, 2026, 4:00 PM EDT
1.630
+0.030 (1.87%)
After-hours: Apr 28, 2026, 7:33 PM EDT

SXTP Stock Forecast

SXTP's stock price has decreased by -86.44% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for SXTP stock have an average target of 14.1, with a low estimate of 4.20 and a high estimate of 24. The average target predicts an increase of 781.25% from the current stock price of 1.60.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $4.20 $14.1 $24 $24
Change +162.50% +781.25% +1400.0% +1400.0%

Analyst Ratings

The average analyst rating for SXTP stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy 222222
Buy 000000
Hold 111110
Sell 000000
Strong Sell 000000
Total 333332

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$11$4.2
Strong Buy Maintains $11$4.2 +162.50% Apr 9, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$6$24
Strong Buy Maintains $6$24 +1,400.00% Jan 27, 2026
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$12$11
Strong Buy Maintains $12$11 +600.00% Nov 28, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$24
Strong Buy Initiates $24 +1,400.00% Nov 14, 2025
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$28$12
Strong Buy Maintains $28$12 +650.00% Sep 3, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
1.89M
from 1.41M
Increased by 33.92%
Revenue Next Year
2.86M
from 1.89M
Increased by 51.35%
EPS This Year
-5.15
from -11.74
EPS Next Year
-0.55
from -5.15
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
6.35M511.21K253.57K681.35K1.41M1.89M2.86M
Revenue Growth
149.18%-91.95%-50.40%168.70%106.81%33.92%51.35%
EPS
-0.23--240.45-74.17-11.74-5.15-0.55
EPS Growth
-------
Forward PE
-------
No. Analysts -----43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 2.1M 2.9M
Avg 1.9M 2.9M
Low 1.7M 2.7M

Revenue Growth

Revenue Growth 202620272028
High
49.0%
55.8%
Avg
33.9%
51.4%
Low
18.2%
45.4%

EPS Forecast

EPS 202620272028
High -2.32 -0.57
Avg -5.15 -0.55
Low -7.72 -0.53

EPS Growth

EPS Growth 202620272028
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.